C
MiMedx Group, Inc. MDXG
$6.68 $0.050.75% NASDAQ
Recommendation
Prev Close
$6.68
Volume
373,721
Avg Vol (90D)
619,680
Market Cap
$984.41M
Dividend & Yield
--
52-Week Range
$5.47 - $10.14
P/E (TTM)
23.65
EPS (TTM)
$0.2825
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
StockNews.com Downgrades MiMedx Group (NASDAQ:MDXG) to Buy
4/19/2025 - MarketBeat
MiMedx Group (MDXG, $6.68) RSI Indicator left the oversold zone on April 17, 2025
4/18/2025 - Tickeron - Technical Analysis
MiMedx Group (MDXG, $6.63) RSI Indicator left the oversold zone on April 16, 2025
4/17/2025 - Tickeron - Stocks
Some Shareholders Feeling Restless Over MiMedx Group, Inc.'s (NASDAQ:MDXG) P/E Ratio
4/17/2025 - Simply Wall St
MIMEDX to Host First Quarter 2025 Operating and Financial Results Conference Call on April 30
4/16/2025 - Globe Newswire
Renaissance Technologies LLC Acquires 280,327 Shares of MiMedx Group, Inc. (NASDAQ:MDXG)
4/15/2025 - MarketBeat
Wellington Management Group LLP Acquires 72,432 Shares of MiMedx Group, Inc. (NASDAQ:MDXG)
4/14/2025 - MarketBeat
417,900 Shares in MiMedx Group, Inc. (NASDAQ:MDXG) Purchased by Norges Bank
4/13/2025 - MarketBeat
Vanguard Group Inc. Sells 262,667 Shares of MiMedx Group, Inc. (NASDAQ:MDXG)
4/13/2025 - MarketBeat
Arrowstreet Capital Limited Partnership Has $3.49 Million Stock Holdings in MiMedx Group, Inc. (NASDAQ:MDXG)
4/11/2025 - MarketBeat
MiMedx Group Inc (MDXG) Announces Participation in Key Industry Conferences MDXG stock news
4/10/2025 - GuruFocus
MIMEDX to Feature Growing Body of Clinical and Scientific Evidence at Upcoming Wound & Surgical-Focused Industry Conferences
4/10/2025 - Globe Newswire
Cannell Capital LLC Acquires 40,235 Shares of MiMedx Group, Inc. (NASDAQ:MDXG)
4/10/2025 - MarketBeat
MiMedx Group (MDXG, $7.16) RSI Indicator left the oversold zone on April 09, 2025
4/10/2025 - Tickeron - Stocks
MiMedx Group (MDXG, $6.86) RSI Indicator left the oversold zone on April 08, 2025
4/9/2025 - Tickeron - Stocks
MiMedx Group (MDXG, $7.09) RSI Indicator left the oversold zone on April 07, 2025
4/8/2025 - Tickeron - Technical Analysis
Peek Under The Hood: SMLF Has 42% Upside
4/8/2025 - ETF Channel
StockNews.com Upgrades MiMedx Group (NASDAQ:MDXG) to "Strong-Buy"
4/7/2025 - MarketBeat
92,207 Shares in MiMedx Group, Inc. (NASDAQ:MDXG) Purchased by Raymond James Financial Inc.
4/6/2025 - MarketBeat
MiMedx Group (MDXG, $7.06) RSI Indicator left the oversold zone on April 04, 2025
4/5/2025 - Tickeron - Stocks
BioHarvest Sciences Inc. (BHST) Reports Q4 Loss, Lags Revenue Estimates
3/31/2025 - Zacks Investment Research
MiMedx Group Breaks Below 200-Day Moving Average - Notable for MDXG
3/28/2025 - Market News Video
MiMedx Group (MDXG, $7.74) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 27, 2025
3/28/2025 - Tickeron - Technical Analysis
MiMedx Group (NASDAQ:MDXG) Seems To Use Debt Rather Sparingly
3/27/2025 - Simply Wall St
EntryPoint Capital LLC Takes Position in MiMedx Group, Inc. (NASDAQ:MDXG)
3/27/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$348.88M
EBITDA (TTM)
$65.35M
EBIT (TTM)
$59.31M
Net Income (TTM)
$42.42M
Balance Sheet
Total Assets (Q)
$263.92M
Total Debt (Q)
$24.84M
Total Liabilities (Q)
$70.81M
Book Value Per Share (Q)
$1.31
Cash Flow
Cash from Operations (TTM)
$66.20M
Cash from Investing (TTM)
-$9.58M
Cash from Financing (TTM)
-$34.20M
Net Change in Cash (TTM)
$22.42M
Filings
Filing Date
Wednesday, February 26, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
End of April (est)
Price History
Loading...
Beta
0.86
7-Day Total Return
-6.70%
30-Day Total Return
-15.34%
60-Day Total Return
-26.02%
90-Day Total Return
-30.99%
Year to Date Total Return
-28.02%
1-Year Total Return
8.44%
2-Year Total Return
98.81%
3-Year Total Return
51.13%
5-Year Total Return
79.81%
52-week Low
Oct 10, 2024 - $5.47
52-week High
Dec 10, 2024 - $10.14
Valuation
Market Cap
$984.41M - Small Cap
Enterprise Value
$904.83M
Price/Sales (TTM)
2.86
Price/Book (Q)
5.08
Dividends and Shares
Shares Outstanding
149.24M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.mimedx.com
Phone Number
770 651 9100
Address
1775 West Oak Commons Court, NE
Marietta, GA 30062
Country
United States
Year Founded
2006
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the... more
NASDAQ 04/17/2025 4:00PM Eastern Quotes delayed